Evaluation shows that continuous glucose monitoring enhances A1C and reduces neonatal complications in pregnant women with type 2 diabetes.
This study evaluated the use of real-time continuous glucose monitoring (CGM) versus blood glucose monitoring (BGM) with a glucose meter in pregnant patients with preexisting type 2 diabetes on insulin therapy. The use of CGM improved A1C and reduced infant morbidity and mortality compared with BGM alone.
No takes yet. Share an insight, caveat, or question.
Nunlee‐Bland et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: